Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects

NCT03401671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Lanadelumab

Sponsor

Shire